PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9857074-1	1998	Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter.	ikaros	38-44	granzyme B	Homo sapiens	81-91	
9857074-3	1998	Granzyme B gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, AP-1, and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation.	ikaros	150-156	granzyme B	Homo sapiens	0-10	
9857074-3	1998	Granzyme B gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, AP-1, and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation.	ikaros	150-156	granzyme B	Homo sapiens	221-231	
9857074-6	1998	Mutation of Ikaros or AP-1 binding sites in the context of the granzyme B promoter demonstrated that both sites participate in dexamethasone-mediated inhibition of the granzyme B promoter activity.	ikaros	12-18	granzyme B	Homo sapiens	63-73	
9857074-6	1998	Mutation of Ikaros or AP-1 binding sites in the context of the granzyme B promoter demonstrated that both sites participate in dexamethasone-mediated inhibition of the granzyme B promoter activity.	ikaros	12-18	granzyme B	Homo sapiens	168-178	
7624346-5	1995	Mutational analysis of the human granzyme B promoter reveals that the Ikaros binding site (-143 to -114) and the AP-1/CBF binding site (-103 to -77) are essential for the activation of transcription in phytohemagglutinin-activated peripheral blood lymphocytes, whereas mutation of the Ets binding site does not affect promoter activity in these cells.	ikaros	70-76	granzyme B	Homo sapiens	33-43